地西他滨联合半量CAG方案治疗骨髓增生异常综合征伴原始细胞增多和急性髓系白血病伴骨髓增生异常相关改变

OBJECTIVE: To evaluate the clinical efficacy and safety of decitabine in combination with lower-dose CAG regimen (G-CSF, cytarabine and aclarubicin; D-CAG regimen) in the treatment of myelodysplastic syndromes with excess blasts (MDS-EB) and acute myeloid leukemia with myelodysplasia-related changes...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2018
Materias:
论著
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342258/
https://www.ncbi.nlm.nih.gov/pubmed/30369183
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.09.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342258/
https://www.ncbi.nlm.nih.gov/pubmed/30369183
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.09.006

Ejemplares similares